Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Galectin Therapeutics Inc (NASDAQ:GALT)

1.13
Delayed Data
As of 4:00pm ET
 -0.09 / -7.38%
Today’s Change
1.08
Today|||52-Week Range
3.25
-31.10%
Year-to-Date
Galectin Therapeutics (GALT) Stock Drops on Drug Failure, Downgraded
Sep 29 / TheStreet.com - Paid Partner Content
5 Biotech Stocks to Watch as Interest in NASH Increases
Sep 22 / Zacks.com - Paid Partner Content
Galectin Therapeutics (GALT) Stock Declines on Drug Failure, Rating Cut
Sep 28 / TheStreet.com - Paid Partner Content
Is Galectin The Next Takeover Target for the Biotech World?
Sep 22 / Zacks.com - Paid Partner Content
Can The Uptrend Continue for Galectin Therapeutics (GALT)?
Sep 23 / Zacks.com - Paid Partner Content